Pfizer Led Top 10 M&A Deals Of Q1 As Values Hit Record Low
Pfizer's $45.7 billion purchase of Seagen Inc. topped the largest global mergers and acquisitions announced in the first quarter of 2023, as the health care, energy, tech, real estate and finance...To view the full article, register now.
Already a subscriber? Click here to view full article